OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze
All-In with Chamath, Jason, Sacks & Friedberg
00:00
Peptide Pricing May Create Premium Tiers
David Friedberg and Chamath Palihapitiya discuss how Lilly could price obesity drugs in tiers, with cheaper current options and retatrutide as a premium upgrade.
Play episode from 01:03:32
Transcript
